Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionDFIS - Dimensional International Small Cap ETF
Latest Disclosed Ownership43,160 shares
Latest Disclosed Value $ 347,307
DFIS - Dimensional International Small Cap ETF reports 12.22% increase in ownership of 4577 / Daito Pharmaceutical Co.,Ltd.

On June 29, 2026 - DFIS - Dimensional International Small Cap ETF filed a NPORT-P form disclosing ownership of 43,160 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $54,424,760 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 38,460 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 12.22% during the quarter. The current value of the position is $58,524,960 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-29 2026-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 43,160 4,700 12.22 347 4.52 0.0062
2026-03-27 2026-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 38,460 1,200 3.22 333 10.67 0.0064
2025-12-29 2025-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 37,260 4,600 14.08 301 14.50 0.0069
2025-09-25 2025-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 32,660 15,880 94.64 262 7.38 0.0078
2025-06-26 2025-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 16,780 1,500 9.82 245 19.61 0.0090
2025-03-28 2025-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 15,280 1,600 11.70 205 2.00 0.0082
2024-12-30 2024-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 13,680 0 0.00 201 -7.83 0.0096
2024-09-27 2024-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 13,680 2,700 24.59 218 23.30 0.0118
2024-06-26 2024-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 10,980 3,500 46.79 176 74.26 0.0112
2024-03-28 2024-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 7,480 3,300 78.95 101 90.57 0.0109
2023-12-28 2023-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 4,180 380 10.00 53 -14.52 0.0074
2023-09-27 2023-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 3,800 0 0.00 63 -11.43 0.0086
2023-06-26 2023-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 3,800 2,000 111.11 71 94.44 0.0110
2023-03-30 2023-01-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,800 0 0.00 36 16.13 0.0065
2022-12-27 2022-10-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,800 0 0.00 31 -11.43 0.0096
2022-09-29 2022-07-31 NP DAITO PHARMACEUTICAL EC JP3486150000 1,800 1,400 350.00 36 337.50 0.0202
2022-06-27 2022-04-30 NP DAITO PHARMACEUTICAL EC JP3486150000 400 400 8 0.0264
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.